U.S. Federal Court Invalidates Certain Mifepristone Restrictions

A federal court in Virginia has determined that specific restrictions on the abortion medication mifepristone, implemented by the previous Trump administration, are unlawful. The ruling mandates a reconsideration of these rules, which included requirements for prescribers and pharmacies to register and be specially certified. This decision stems from a challenge by the Center for Reproductive Rights regarding the drug's Risk Evaluation and Mitigation Strategy. The outcome could influence access to the medication.